Rong Zhang

Rong Zhang

Auto-generated profile, based on publicly available information

Rong Zhang

Institute of Tissue Regeneration and Wound Repair, Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China, sdutcm.edu.cn

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
RZRong Zhang
Rong Zhang
ZSZhanshuai Song
Zhanshuai Song
JZJuan Zhang
Juan Zhang
WZWenwen Zhang
Wenwen Zhang
LLLinlin Li
Linlin Li
KMKai Mou
Kai Mou
Diabetic foot ulcer (DFU) is one of the most severe complications of diabetes, characterized by high rates of morbidity, disability, and mortality. Current treatment modalities for DFU primarily include surgical debridement, negative‐pressure wound therapy, and anti‐infection measures. However, these approaches are limited by prolonged treatment duration, high costs, and suboptimal therapeutic outcomes. Adipose‐derived mesenchymal stem cells (ADMSCs) have garnered significant attention in wound repair and tissue regeneration due to their ability to secrete a variety of cytokines involved in the healing process. Exosomes, as key mediators of the paracrine effects underlying the therapeutic benefits of ADMSCs, are emerging as promising agents for wound repair. As a novel therapeutic strategy, exosomes have been increasingly investigated for the treatment of DFU. In this review, we summarize the applications and therapeutic potential of ADMSC‐exosomes in DFU, aiming to provide a valuable reference for its clinical management.